Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


After Recusal, Schnedar Leaving CDER Compliance Office

This article was originally published in The Pink Sheet Daily

Executive Summary

Cynthia Schnedar decides to leave several weeks after FDA determined that her husband's promotion could create conflicts of interest.


Related Content

US FDA’s New Compliance Chief Donald Ashley Brings International Law Enforcement Experience
Despite Globalization, Three Quarters of Serious Inspection Issues FDA Found Were in US
Show Me The Money: FDA Recruitment Efforts Challenged By Government Salaries
Mylan Grabs More FDA Globalization Talent
Industry Responds to FDA’s Quality Metrics Initiative with Proposal to Report Trends, not Values


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts